Familial Prostate CancerSymptoms, Doctors, Treatments, Advances & More
Familial Prostate Cancer Overview
Learn About Familial Prostate Cancer
View Main Condition: Prostate Cancer
- Familial prostate cancer
- Hereditary prostate cancer
- Prostate cancer, familial
- Prostate cancer, hereditary
University Of Chicago
Scott Eggener is a Urologist in Chicago, Illinois. Dr. Eggener is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Prostate Cancer, Testicular Cancer, Familial Prostate Cancer, Prostatectomy, and Nephrectomy. Dr. Eggener is currently accepting new patients.
William Catalona is a Urologist in Chicago, Illinois. Dr. Catalona has been practicing medicine for over 58 years and is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Bacterial Prostatitis, Prostatectomy, and Vasectomy.
Jefferson Cancer - Honickman Center
William Kelly is an Oncologist in Philadelphia, Pennsylvania. Dr. Kelly is rated as an Elite provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Chromophobe Renal Cell Carcinoma, Orchiectomy, and Prostatectomy. Dr. Kelly is currently accepting new patients.
Summary: This study aims to help patients with prostate cancer and their spouses cope better with the challenges of cancer by learning and supporting each other together. The investigators will test an 8-week Dyadic Co-learning Intervention, which includes weekly learning topics, a mobile app, and professional support. The goal is to improve their physical symptoms, emotional well-being, and resilience. Pa...
Summary: This phase II trial evaluates the impact of cancer therapy in the patients' home compared to in the clinic on safety, side effects, patient preference, and satisfaction in Black men with prostate cancer that has spread to nearby tissue or lymph nodes (locally advanced), that has increasing prostate-specific antigen after treatment (biochemically recurrent) or that has spread from where it first st...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

